Funder
CellCAN – Regenerative Medicine and Cell Therapy Network
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)
Reference71 articles.
1. Illes J, Sipp D, Kleiderman E, Benjaminy S, Isasi R, Lomax G, et al. A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine. npj Regenerative Medicine. 2017;2(1):21.
2. Crowe K. Unapproved stem cell therapies on the market in Canada: CBC News; 2017.
http://www.cbc.ca/news/health/stem-cell-private-clinic-health-canada-osteoarthritis-1.4401391
. Accessed 11 June 2018
3. Mason C, McCall Mark J, Culme-Seymour Emily J, Suthasan S, Edwards-Parton S, Bonfiglio Gregory A, et al. The global cell therapy industry continues to rise during the second and third quarters of 2012. Cell Stem Cell. 2012;11(6):735–9.
4. Heathman TR, Nienow AW, McCall MJ, Coopman K, Kara B, Hewitt CJ. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen Med. 2015;10(1):49–64.
5. Dodson BP, Levine AD. Challenges in the translation and commercialization of cell therapies. BMC Biotechnol. 2015;15(1):70.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献